ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 3,900 shares, a drop of 7.1% from the November 30th total of 4,200 shares. Based on an average daily volume of 12,300 shares, the days-to-cover ratio is presently 0.3 days.

ProShares Ultra Nasdaq Biotechnology Stock Up 0.7 %

Shares of ProShares Ultra Nasdaq Biotechnology stock traded up $0.35 on Tuesday, reaching $50.58. 5,715 shares of the company traded hands, compared to its average volume of 22,065. The company has a 50 day moving average of $58.14 and a 200 day moving average of $61.69. ProShares Ultra Nasdaq Biotechnology has a 52 week low of $47.19 and a 52 week high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd will be given a $0.3964 dividend. The ex-dividend date of this dividend is Monday, December 23rd. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Inflows and Outflows

An institutional investor recently raised its position in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC grew its stake in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 8.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,803 shares of the exchange traded fund’s stock after acquiring an additional 374 shares during the period. Jane Street Group LLC owned 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 at the end of the most recent reporting period.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Featured Stories

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.